Trial
NCT00979940
Effects of Short Term, High Dose Atorvastatin Therapy on Periprocedural Myonecrosis and Platelet Inhibition After Percutaneous Coronary Intervention (PCI)
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Indiana University
Collaborators
National Center for Research Resources (NCRR)
Condition
Coronary Artery Disease
Intervention
Atorvastatin
Why stopped
Slower than anticipated enrollment for pilot study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-09-22